Rational design, synthesis and characterization of potent, non-peptidic Smac mimics/XIAP inhibitors as proapoptotic agents for cancer therapy.
about
Recognition of Smac-mimetic compounds by the BIR domain of cIAP1Structural Insight into Inhibitor of Apoptosis Proteins Recognition by a Potent Divalent Smac-MimeticInducing death in tumor cells: roles of the inhibitor of apoptosis proteins.Novel SMAC-mimetics synergistically stimulate melanoma cell death in combination with TRAIL and BortezomibExpression of executioner procaspases and their activation by a procaspase-activating compound in chronic lymphocytic leukemia cellsProapoptotic activity of a monomeric smac mimetic on human fibroblast-like synoviocytes from patients with rheumatoid arthritis.Smac127 Has Proapoptotic and Anti-Inflammatory Effects on Rheumatoid Arthritis Fibroblast-Like SynoviocytesSmac mimetics induce inflammation and necrotic tumour cell death by modulating macrophage activity.Reactivation of Smac-mediated apoptosis in chronic lymphocytic leukemia cells: mechanistic studies of Smac mimetic.Synthesis and biological evaluation of dual action cyclo-RGD/SMAC mimetic conjugates targeting α(v)β(3)/α(v)β(5) integrins and IAP proteins.Novel second mitochondria-derived activator of caspases (Smac) mimetic compounds sensitize human leukemic cell lines to conventional chemotherapeutic drug-induced and death receptor-mediated apoptosis.A NMR and computational study of Smac mimics targeting both the BIR2 and BIR3 domains in XIAP protein.
P2860
Q27665119-8867156B-FEB8-4517-81FA-C8EF64DA9181Q27675179-24C67467-AEA0-4DBB-AE45-9DE06D4C8A8BQ33632016-E00F2A8E-BEC7-42F1-9558-0DBBC8938519Q33906039-FF50629A-AEC9-4A90-8E3B-C891AB369145Q34455521-10DF6356-E200-43D7-9B8C-CBFEEB19A359Q35033204-F1CE61B2-A474-44FA-B702-88F7B46BF421Q36637550-0310D6CF-B9EF-4CB8-B521-021C7787D5D5Q37357090-2E5BE41A-26EA-46D1-8222-ADA5357869BAQ37457562-B4C82E38-D32E-4DA0-9805-ADEA9861C65FQ39003639-8C306705-7B20-4B0C-B587-85B09EE12CD6Q39682910-CC951854-B7B8-4C2B-AE0A-51B2F7653A41Q46806247-B2AA7475-0CA6-48F5-B357-C4DA505B2D2E
P2860
Rational design, synthesis and characterization of potent, non-peptidic Smac mimics/XIAP inhibitors as proapoptotic agents for cancer therapy.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Rational design, synthesis and ...... tic agents for cancer therapy.
@en
Rational design, synthesis and ...... tic agents for cancer therapy.
@nl
type
label
Rational design, synthesis and ...... tic agents for cancer therapy.
@en
Rational design, synthesis and ...... tic agents for cancer therapy.
@nl
prefLabel
Rational design, synthesis and ...... tic agents for cancer therapy.
@en
Rational design, synthesis and ...... tic agents for cancer therapy.
@nl
P2093
P50
P1476
Rational design, synthesis and ...... otic agents for cancer therapy
@en
P2093
Aldo Bianchi
Amira Khaled
Andrea Caprini
Carlo Scolastico
Carmelo Drago
Domenico Delia
Elena de Franco
Elisa Turlizzi
Elisabetta Moroni
Federica Servida
P304
P356
10.1016/J.BMC.2009.07.009
P407
P50
P577
2009-07-10T00:00:00Z